Multilaboratory evaluation of disk diffusion antimicrobial susceptibility testing of Neisseria meningitidis isolates

James H. Jorgensen, Sharon A. Crawford, Letitia C. Fulcher, Anita Glennen, Susan M. Harrington, Jana Swenson, Ruth Lynfield, Patrick R. Murray, Fred C. Tenover

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

In 2005, the Clinical and Laboratory Standards Institute published MIC interpretive criteria for 13 antimicrobial agents used for either therapy or prophylaxis of Neisseria meningitidis infections. The MIC method includes the use of lysed horse blood-supplemented Mueller-Hinton broth with incubation in 5% CO2 for 20 to 24 h. Since some clinical laboratories might prefer the option of disk diffusion testing for infrequently encountered isolates a multicenter collaborative study was conducted to evaluate the reproducibility of a disk diffusion method for testing isolates of N. meningitidis. Interpretive criteria were developed for 12 antimicrobial agents. Four laboratories tested a common collection of 50 meningococcal strains and then tested 25 unique isolates per laboratory. Isolates were tested using Mueller-Hinton sheep blood agar plates incubated for 20 to 24 h in 5% CO2; they were also tested by the reference broth microdilution method in parallel. Pooling of the MIC and disk diffusion data from the common and unique isolates provided a sufficient sample size to develop susceptible, intermediate, and resistant zone diameter interpretive criteria using the error rate-bounded method for the following agents: chloramphenicol, trimethoprim-sulfamethoxazole, ciprofloxacin, and rifampin. Due to the lack of resistant strains at the present time, "susceptible only" interpretive criteria were proposed for cefotaxime, ceftriaxone, meropenem, azithromycin, and minocycline. The numbers of minor interpretive errors with penicillin and ampicillin disk tests were unacceptably high and precluded recommended testing of those agents by the disk method. However, amdinocillin, an agent that preferentially binds to the altered penicillin binding protein responsible for diminished penicillin susceptibility, has potential utility as a surrogate screening reagent for ampicillin resistance. A disk diffusion breakpoint was derived for nalidixic acid to serve as a surrogate marker for gyrase A mutations associated with diminished fluoroquinolone susceptibility. Disk diffusion testing with meningococci can be performed in a reproducible manner with several antimicrobial agents and represents a practical and cost-effective option for testing sporadic clinical isolates or for surveillance purposes by resource-limited laboratories.

Original languageEnglish (US)
Pages (from-to)1744-1754
Number of pages11
JournalJournal of Clinical Microbiology
Volume44
Issue number5
DOIs
StatePublished - May 2006

Fingerprint

Neisseria meningitidis
Anti-Infective Agents
meropenem
Penicillins
Amdinocillin
Ampicillin Resistance
Penicillin-Binding Proteins
Nalidixic Acid
Minocycline
Azithromycin
Cefotaxime
Ceftriaxone
Fluoroquinolones
Sulfamethoxazole Drug Combination Trimethoprim
Chloramphenicol
Ampicillin
Rifampin
Ciprofloxacin
Sample Size
Horses

ASJC Scopus subject areas

  • Microbiology (medical)
  • Microbiology

Cite this

Jorgensen, J. H., Crawford, S. A., Fulcher, L. C., Glennen, A., Harrington, S. M., Swenson, J., ... Tenover, F. C. (2006). Multilaboratory evaluation of disk diffusion antimicrobial susceptibility testing of Neisseria meningitidis isolates. Journal of Clinical Microbiology, 44(5), 1744-1754. https://doi.org/10.1128/JCM.44.5.1744-1754.2006

Multilaboratory evaluation of disk diffusion antimicrobial susceptibility testing of Neisseria meningitidis isolates. / Jorgensen, James H.; Crawford, Sharon A.; Fulcher, Letitia C.; Glennen, Anita; Harrington, Susan M.; Swenson, Jana; Lynfield, Ruth; Murray, Patrick R.; Tenover, Fred C.

In: Journal of Clinical Microbiology, Vol. 44, No. 5, 05.2006, p. 1744-1754.

Research output: Contribution to journalArticle

Jorgensen, JH, Crawford, SA, Fulcher, LC, Glennen, A, Harrington, SM, Swenson, J, Lynfield, R, Murray, PR & Tenover, FC 2006, 'Multilaboratory evaluation of disk diffusion antimicrobial susceptibility testing of Neisseria meningitidis isolates', Journal of Clinical Microbiology, vol. 44, no. 5, pp. 1744-1754. https://doi.org/10.1128/JCM.44.5.1744-1754.2006
Jorgensen, James H. ; Crawford, Sharon A. ; Fulcher, Letitia C. ; Glennen, Anita ; Harrington, Susan M. ; Swenson, Jana ; Lynfield, Ruth ; Murray, Patrick R. ; Tenover, Fred C. / Multilaboratory evaluation of disk diffusion antimicrobial susceptibility testing of Neisseria meningitidis isolates. In: Journal of Clinical Microbiology. 2006 ; Vol. 44, No. 5. pp. 1744-1754.
@article{156f9aa0400745f5bf58cac616e5b00f,
title = "Multilaboratory evaluation of disk diffusion antimicrobial susceptibility testing of Neisseria meningitidis isolates",
abstract = "In 2005, the Clinical and Laboratory Standards Institute published MIC interpretive criteria for 13 antimicrobial agents used for either therapy or prophylaxis of Neisseria meningitidis infections. The MIC method includes the use of lysed horse blood-supplemented Mueller-Hinton broth with incubation in 5{\%} CO2 for 20 to 24 h. Since some clinical laboratories might prefer the option of disk diffusion testing for infrequently encountered isolates a multicenter collaborative study was conducted to evaluate the reproducibility of a disk diffusion method for testing isolates of N. meningitidis. Interpretive criteria were developed for 12 antimicrobial agents. Four laboratories tested a common collection of 50 meningococcal strains and then tested 25 unique isolates per laboratory. Isolates were tested using Mueller-Hinton sheep blood agar plates incubated for 20 to 24 h in 5{\%} CO2; they were also tested by the reference broth microdilution method in parallel. Pooling of the MIC and disk diffusion data from the common and unique isolates provided a sufficient sample size to develop susceptible, intermediate, and resistant zone diameter interpretive criteria using the error rate-bounded method for the following agents: chloramphenicol, trimethoprim-sulfamethoxazole, ciprofloxacin, and rifampin. Due to the lack of resistant strains at the present time, {"}susceptible only{"} interpretive criteria were proposed for cefotaxime, ceftriaxone, meropenem, azithromycin, and minocycline. The numbers of minor interpretive errors with penicillin and ampicillin disk tests were unacceptably high and precluded recommended testing of those agents by the disk method. However, amdinocillin, an agent that preferentially binds to the altered penicillin binding protein responsible for diminished penicillin susceptibility, has potential utility as a surrogate screening reagent for ampicillin resistance. A disk diffusion breakpoint was derived for nalidixic acid to serve as a surrogate marker for gyrase A mutations associated with diminished fluoroquinolone susceptibility. Disk diffusion testing with meningococci can be performed in a reproducible manner with several antimicrobial agents and represents a practical and cost-effective option for testing sporadic clinical isolates or for surveillance purposes by resource-limited laboratories.",
author = "Jorgensen, {James H.} and Crawford, {Sharon A.} and Fulcher, {Letitia C.} and Anita Glennen and Harrington, {Susan M.} and Jana Swenson and Ruth Lynfield and Murray, {Patrick R.} and Tenover, {Fred C.}",
year = "2006",
month = "5",
doi = "10.1128/JCM.44.5.1744-1754.2006",
language = "English (US)",
volume = "44",
pages = "1744--1754",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "5",

}

TY - JOUR

T1 - Multilaboratory evaluation of disk diffusion antimicrobial susceptibility testing of Neisseria meningitidis isolates

AU - Jorgensen, James H.

AU - Crawford, Sharon A.

AU - Fulcher, Letitia C.

AU - Glennen, Anita

AU - Harrington, Susan M.

AU - Swenson, Jana

AU - Lynfield, Ruth

AU - Murray, Patrick R.

AU - Tenover, Fred C.

PY - 2006/5

Y1 - 2006/5

N2 - In 2005, the Clinical and Laboratory Standards Institute published MIC interpretive criteria for 13 antimicrobial agents used for either therapy or prophylaxis of Neisseria meningitidis infections. The MIC method includes the use of lysed horse blood-supplemented Mueller-Hinton broth with incubation in 5% CO2 for 20 to 24 h. Since some clinical laboratories might prefer the option of disk diffusion testing for infrequently encountered isolates a multicenter collaborative study was conducted to evaluate the reproducibility of a disk diffusion method for testing isolates of N. meningitidis. Interpretive criteria were developed for 12 antimicrobial agents. Four laboratories tested a common collection of 50 meningococcal strains and then tested 25 unique isolates per laboratory. Isolates were tested using Mueller-Hinton sheep blood agar plates incubated for 20 to 24 h in 5% CO2; they were also tested by the reference broth microdilution method in parallel. Pooling of the MIC and disk diffusion data from the common and unique isolates provided a sufficient sample size to develop susceptible, intermediate, and resistant zone diameter interpretive criteria using the error rate-bounded method for the following agents: chloramphenicol, trimethoprim-sulfamethoxazole, ciprofloxacin, and rifampin. Due to the lack of resistant strains at the present time, "susceptible only" interpretive criteria were proposed for cefotaxime, ceftriaxone, meropenem, azithromycin, and minocycline. The numbers of minor interpretive errors with penicillin and ampicillin disk tests were unacceptably high and precluded recommended testing of those agents by the disk method. However, amdinocillin, an agent that preferentially binds to the altered penicillin binding protein responsible for diminished penicillin susceptibility, has potential utility as a surrogate screening reagent for ampicillin resistance. A disk diffusion breakpoint was derived for nalidixic acid to serve as a surrogate marker for gyrase A mutations associated with diminished fluoroquinolone susceptibility. Disk diffusion testing with meningococci can be performed in a reproducible manner with several antimicrobial agents and represents a practical and cost-effective option for testing sporadic clinical isolates or for surveillance purposes by resource-limited laboratories.

AB - In 2005, the Clinical and Laboratory Standards Institute published MIC interpretive criteria for 13 antimicrobial agents used for either therapy or prophylaxis of Neisseria meningitidis infections. The MIC method includes the use of lysed horse blood-supplemented Mueller-Hinton broth with incubation in 5% CO2 for 20 to 24 h. Since some clinical laboratories might prefer the option of disk diffusion testing for infrequently encountered isolates a multicenter collaborative study was conducted to evaluate the reproducibility of a disk diffusion method for testing isolates of N. meningitidis. Interpretive criteria were developed for 12 antimicrobial agents. Four laboratories tested a common collection of 50 meningococcal strains and then tested 25 unique isolates per laboratory. Isolates were tested using Mueller-Hinton sheep blood agar plates incubated for 20 to 24 h in 5% CO2; they were also tested by the reference broth microdilution method in parallel. Pooling of the MIC and disk diffusion data from the common and unique isolates provided a sufficient sample size to develop susceptible, intermediate, and resistant zone diameter interpretive criteria using the error rate-bounded method for the following agents: chloramphenicol, trimethoprim-sulfamethoxazole, ciprofloxacin, and rifampin. Due to the lack of resistant strains at the present time, "susceptible only" interpretive criteria were proposed for cefotaxime, ceftriaxone, meropenem, azithromycin, and minocycline. The numbers of minor interpretive errors with penicillin and ampicillin disk tests were unacceptably high and precluded recommended testing of those agents by the disk method. However, amdinocillin, an agent that preferentially binds to the altered penicillin binding protein responsible for diminished penicillin susceptibility, has potential utility as a surrogate screening reagent for ampicillin resistance. A disk diffusion breakpoint was derived for nalidixic acid to serve as a surrogate marker for gyrase A mutations associated with diminished fluoroquinolone susceptibility. Disk diffusion testing with meningococci can be performed in a reproducible manner with several antimicrobial agents and represents a practical and cost-effective option for testing sporadic clinical isolates or for surveillance purposes by resource-limited laboratories.

UR - http://www.scopus.com/inward/record.url?scp=33646562482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646562482&partnerID=8YFLogxK

U2 - 10.1128/JCM.44.5.1744-1754.2006

DO - 10.1128/JCM.44.5.1744-1754.2006

M3 - Article

C2 - 16672402

AN - SCOPUS:33646562482

VL - 44

SP - 1744

EP - 1754

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 5

ER -